Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.
Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.
''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.
O'Romeo Box Office Collection Day 3: Ind Vs Pak Match Affects Shahid-Triptii Starrer; Movie Drops, Collects ₹9 Crore
Study Abroad Dream Cools Down: Govt Data Show 31% Drop In Indians Studying Abroad Since 2023
Angry Pakistani Fan Smashes TV After Embarrassing 61-Run Loss To Team India At ICC T20 World Cup; Video
Ind Vs Pak ICC T20 World Cup: Ajay Devgn, Smriti Irani, Ayushmann Khurrana Bollywood & TV Celebrate India's Win
(With inputs from PTI)
